Yasutaka Yamamoto - Publications

Bilateral renal subcapsular hematoma caused by polyarteritis nodosa: a case report.

Journal: CEN case reports

Published: October 04, 2021

Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 24, 2017

Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.

Journal: International journal of molecular medicine

Published: March 22, 2016

Streptococcal Infection-related Nephritis (SIRN) Manifesting Membranoproliferative Glomerulonephritis Type I.

Journal: Internal medicine (Tokyo, Japan)

Published: March 18, 2016

Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.

Journal: American journal of physiology. Renal physiology

Published: March 15, 2016

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.

Journal: PloS one

Published: February 13, 2016

Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats.

Journal: PloS one

Published: May 10, 2014

Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.

Journal: PloS one

Published: August 22, 2012